LQDA

Conviction 88HealthcareScan · Mon, Aug 10, 2026

LQDA$91.06+0.93%

ResistanceSupportVol 14Insider buyInsider sell

Vol MA14 1.37M

May 11May 28Jun 16Jul 6Jul 23Aug 10

Liquidia CorpPHARMACEUTICAL PREPARATIONSwww.liquidia.com ↗

Price91.06

Change+0.93%

Gap-1.42%

Rel volume1.39×

Avg volume1.29M

Avg $ vol109.45M

SMA 2084.54

SMA 5076.52

SMA 20046.90

Price vs 50+19.01%

Price vs 200+94.17%

MA stackbullish

50/200 cross—

Supertrendup · 76.09

RSI (14)66

MACD hist0.07

MACD crossbull · 1d

Stoch %K / %D91 / 89

ADX (14)22

+DI / −DI23 / 15

RSI divergence—

MACD divergence—

ATR %+5.20%

ADR %5.97%

52w high91.06

52w low20.45

From 52w high+0.00%

Above 52w low+345.28%

New 52w highYes

SqueezeOff

Bollinger width22.86%

%B0.84

Donchian pos94.07%

Donchian high92.30

Donchian low71.40

AVWAP (52w high)90.44

vs AVWAP high+0.69%

AVWAP (52w low)40.11

vs AVWAP low+127.02%

OBV trendUp

Chaikin MF (20)0.21

Today vs 20d1.39×

Avg vol (14d)1.37M

Avg vol (20d)1.29M

Avg $ vol (20d)109.45M

Market cap—

RS 3m (vs SPY)+107.69%

RS 6m (vs SPY)+102.97%

RS line new highNo

Trend template8/8

Technical rank94.3

1 week+8.60%

1 month+16.85%

3 months+115.27%

6 months+111.57%

1 year+374.02%

YTD+190.00%

P/E-116.35

P/B73.86

P/S50.65

P/FCF-200.38

EPS-0.8000

Div yield—

ROE-63.48%

ROA-17.17%

Debt/Eq0.18

Current2.22

EV/EBITDA-156.81

Gross margin—

Net margin-43.53%

Rev growth1031.18%

EPS growth46.28%

Price target87.29

Target upside-3.20%

Analyst ratingBuy

Institutional81.96%

Ent. value7.82B

Revenue132.87M

Net income52.86M

Gross profit—

Free cash flow-40.02M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out88.93M

Employees216

ListedThu, Jul 26, 2018

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA

Conviction88 / 100

Pattern quality—

Tech rank94.3 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance87.03

Support68.13

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in LQDA

All disclosures →

No recent disclosed trades by Congress in LQDA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in LQDA · 2 buys · 8 sells

Insider	Side	Shares	Value	Traded	Filed
Bloch Stephen M Director · Common Stock · 2026-07-21	Sell	74.44K	$6.0M	2026-07-21	2026-07-22
Bloch Stephen M Director · Common Stock · 2026-07-21	Sell	556	$45K	2026-07-21	2026-07-22
Bloch Stephen M Director · Common Stock · 2026-07-20	Sell	3.6K	$286K	2026-07-20	2026-07-22
Bloch Stephen M Director · Common Stock · 2026-07-07	Sell	22.72K	$1.8M	2026-07-07	2026-07-08
Bloch Stephen M Director · Common Stock · 2026-07-07	Sell	27.28K	$2.2M	2026-07-07	2026-07-08
Bloch Stephen M Director · Common Stock · 2026-07-06	Sell	25K	$2.0M	2026-07-06	2026-07-08
Bloch Stephen M Director · Common Stock · 2026-06-22	Sell	30.5K	$2.3M	2026-06-22	2026-06-24
Bloch Stephen M Director · Common Stock · 2026-06-22	Sell	69.5K	$5.3M	2026-06-22	2026-06-24
Horobin Joanna Director · Common Stock · 2026-06-16	Grant	5.88K	—	2026-06-16	2026-06-18
Bloch Stephen M Director · Common Stock · 2026-06-16	Grant	5.88K	—	2026-06-16	2026-06-18

SEC filings

EDGAR filings in LQDA · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.